Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
14-Jul-2025 | 558.95 | 560 | 550 | 550.8 | 11,580 | 9,07,78,651.65 | 94,101 |
15-Jul-2025 | 553 | 564.4 | 550.45 | 556.85 | 13,760 | 26,65,98,819.75 | 3,78,279 |
16-Jul-2025 | 556.85 | 568.7 | 553.2 | 561.6 | 9,425 | 9,08,36,222.2 | 86,943 |
17-Jul-2025 | 569 | 569.8 | 559 | 560.2 | 7,812 | 7,85,14,669.75 | 81,728 |
18-Jul-2025 | 561 | 563 | 551.6 | 552.85 | 6,223 | 6,42,86,948.55 | 64,142 |
21-Jul-2025 | 553 | 555 | 538.7 | 544.65 | 13,292 | 19,96,16,663.45 | 2,17,074 |
22-Jul-2025 | 544.65 | 546.85 | 536.15 | 537.75 | 10,041 | 15,05,70,187.45 | 1,98,757 |
23-Jul-2025 | 537.55 | 543.65 | 535.05 | 540.95 | 7,121 | 4,80,46,509.45 | 34,239 |
24-Jul-2025 | 540.95 | 545.25 | 536.5 | 537.4 | 5,543 | 3,56,90,183.25 | 33,045 |
25-Jul-2025 | 538 | 542.4 | 528.9 | 530.2 | 10,782 | 6,16,15,857.35 | 66,317 |
28-Jul-2025 | 530.5 | 539.75 | 526 | 529.55 | 12,772 | 10,75,32,736.3 | 1,41,653 |
29-Jul-2025 | 535 | 547.65 | 525.25 | 545.4 | 5,278 | 5,12,58,258.55 | 48,668 |
30-Jul-2025 | 546.7 | 550.95 | 536.55 | 539.1 | 7,026 | 9,05,00,562.4 | 1,22,616 |
31-Jul-2025 | 530 | 540 | 511.7 | 519.25 | 18,303 | 38,26,25,347.05 | 5,42,994 |
01-Aug-2025 | 520 | 524.85 | 510.7 | 513.9 | 9,857 | 13,68,62,547.75 | 1,77,096 |
04-Aug-2025 | 511 | 515.05 | 502.95 | 505.2 | 11,015 | 14,93,98,602.35 | 2,22,944 |
05-Aug-2025 | 509 | 513.7 | 499.3 | 502.35 | 7,499 | 6,63,14,704.7 | 71,053 |
06-Aug-2025 | 502.1 | 502.1 | 483.8 | 487.05 | 10,208 | 9,35,36,457.6 | 1,29,978 |
07-Aug-2025 | 486 | 500 | 477.3 | 490.8 | 17,643 | 11,68,81,064.35 | 1,19,421 |
08-Aug-2025 | 495 | 495 | 477.35 | 480.35 | 6,680 | 9,10,79,782.6 | 95,047 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
